IDT ripples the science world with promising Ran protein discovery The annual incidence of breast cancer (BC) in the UK is 50,000 and around 1,000 die from BC every month. 5/100 BC patients have metastasis when first diagnosed, and a further 35/100 will develop metastasis within 10 years, representing considerable disease burden. The challenge is […]

IDT wins prestigious Innovate UK: Biomedical catalyst Award grant for our innovative cancer diagnostic The aim of the Biomedical Catalyst is to support the development of innovative healthcare products, technologies and processes. These can include (but are not limited to): • Disease prevention and proactive management of health and chronic conditions • Earlier and better […]

IMHOTEP (IDX) PROMOTE CLINICAL CHEMISTRY, PT AND APTT BY 10% DISCOUNT.